Peishuang Xu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Peishuang Xu

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Biochimica Et Biophysica Acta. Reviews on Cancer|April 25, 2025

PD-1/PD-L1 blockade therapy in hepatocellular carcinoma: Current status and potential biomarkersPeishuang Xu, Chang Hong, Li Liu, et al.

BMC Medicine|April 12, 2024

PREX2 contributes to radiation resistance by inhibiting radiotherapy-induced tumor immunogenicity via cGAS/STING/IFNs pathway in colorectal cancerMingzhou Li, Jianbiao Xiao, Shasha Song, et al.

Journal of Advanced Research|February 11, 2026

Multi-modal gradual fusion transformer-based model for predicting immunotherapy response in patients with hepatocellular carcinomaLushan Xiao, Jiaren Wang, Hao Cui, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Biochimica Et Biophysica Acta. Reviews on Cancer|April 25, 2025

PD-1/PD-L1 blockade therapy in hepatocellular carcinoma: Current status and potential biomarkersPeishuang Xu, Chang Hong, Li Liu, et al.

BMC Medicine|April 12, 2024

PREX2 contributes to radiation resistance by inhibiting radiotherapy-induced tumor immunogenicity via cGAS/STING/IFNs pathway in colorectal cancerMingzhou Li, Jianbiao Xiao, Shasha Song, et al.

Journal of Advanced Research|February 11, 2026

Multi-modal gradual fusion transformer-based model for predicting immunotherapy response in patients with hepatocellular carcinomaLushan Xiao, Jiaren Wang, Hao Cui, et al.

Pageof 1